Septerna Inc (SEPN)

Dec 18, 2024, 8:00 AM EST - 4 weeks ago

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 7:00 AM EST - 2 months ago

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 19, 2024, 2:10 PM EST - 2 months ago

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones

Oct 30, 2024, 4:41 PM EDT - 2 months ago

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

Oct 26, 2024, 1:30 AM EDT - 3 months ago

U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names

INGM LBGJ PRB ROLR SAG SNYR

Oct 25, 2024, 12:25 PM EDT - 3 months ago

Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut

Oct 24, 2024, 9:47 PM EDT - 3 months ago

Septerna Prices Upsized Initial Public Offering

Oct 24, 2024, 8:11 AM EDT - 3 months ago

Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO

Oct 21, 2024, 6:26 AM EDT - 3 months ago

Biotech Septerna aims to raise up to $186 million in US IPO

Oct 7, 2024, 11:36 AM EDT - 3 months ago

Septerna Pursues $100 Million IPO For Endocrine And Metabolic Drug Pipeline

Oct 2, 2024, 4:22 PM EDT - 3 months ago

Septerna IPO Registration Document (S-1)